(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RX ANALYTIC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RX ANALYTIC

ST13

US500000078897971

Class

5

Filing

78897971

Registration

3455647

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

10/29/2018

Trademark type

Word

Nice classes

5

Filing date

06/01/2006

Registration date

06/24/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/29/2018

Last transaction

10/29/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2006-00-00

First use in commerce

2006-00-00

Drawing code

4

Owner type

01

Owner location

Ridgefield, CT

Examiner

TIERNEY, MARGERY

Law office

M20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Goldstein, Michael

Representatives

Goldstein, Michael

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical evaluation and preparations for the treatment of immunogenic and pathogenic disease; drug delivery agents consisting of nano-pharmaceutical compounds that facilitate a wide range for pharmaceuticals

Publications

History of USPTO decisions and trademark events.

30 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/29/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/29/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/29/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/29/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/18/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

10/18/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/24/2017

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

06/30/2014

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

06/30/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/27/2014

ES8R

TEAS SECTION 8 RECEIVED

06/17/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

06/24/2008

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

05/20/2008

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/20/2008

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/02/2008

IUAF

USE AMENDMENT FILED

04/16/2008

EISU

TEAS STATEMENT OF USE RECEIVED

04/16/2008

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

10/23/2007

PUBO

PUBLISHED FOR OPPOSITION

07/31/2007

NPUB

NOTICE OF PUBLICATION

07/11/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/11/2007

ALIE

ASSIGNED TO LIE

05/11/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/24/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/24/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/24/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/24/2007

CNRT

NON-FINAL ACTION MAILED

11/03/2006

CNRT

NON-FINAL ACTION WRITTEN

11/02/2006

DOCK

ASSIGNED TO EXAMINER

11/02/2006

NWAP

NEW APPLICATION ENTERED

06/06/2006

Continuous trademark protection

Get notified about every new filing that threatens RX ANALYTIC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.